The EPS projection of Monsanto Company (NYSE:MON) for quarter ended 2016-11-30 is $0.1. Last week, the projection for EPS was $0.1 against target of $0.1, a month earlier. While 2-months ago, this projection was $0.1 versus forecast of $0.1a quarter months earlier, posting a deviation of 0%.
Monsanto Company (NYSE:MON) posted that 18 days earlier, the share price was revised 0 times on upside. In addition, negative revisions were 1.
In last week, negative EPS revisions were 0 times and positive EPS revisions were 0 times. In last one-month and two month the positive revisions were 0 and 0. While in last 120 and 90 days, positive revisions were 0, and 0, correspondingly.
The per-share earnings downgrade for Monsanto Company (NYSE:MON) in the preceding 30 and 120 were 0 and 1. While in 60 and 90 days were 0, and 0, in that order.
Monsanto Company (NYSE:MON) EPS target was $0.1 for the quarter closed 3. It was based on 8 calls. As on 2016-06-29 the EPS was $2.17. The change was $-0.24, posting a deviation of -9.96%. The price projections gave a standard deviation of 0.15.
Quarterly Sales Estimates
Monsanto Company (NYSE:MON) sales prediction for the fiscal 2016 stands at $2353.915 and the median estimate is at $2353.915. Almost 2 analysts gave sales target.
Among this, the highest sales estimate is $2469 while the lowest target is $2238.83 showing standard deviation of 162.754%.
As many as 2 analysts have positive sales targets revision while 2 reduced sales estimates, posting a deviation of 0%.
Last month, 2 experts have positive sales number revision. Also, 2 research groups lowered the sales projections, posting a deviation of -4.43%.
A quarter ago, 2 hiked sales target and 2 reduced sales forecast, posting a deviation of -3.141%.
1 Chart Pattern Every Investor Should Know
This little-known pattern preceded moves of 578% in ARWR, 562% in LCI, 513% in ICPT, 439% in EGRX, 408% in ADDUS and more...